{"id":4585,"date":"2023-03-28T16:24:43","date_gmt":"2023-03-28T14:24:43","guid":{"rendered":"https:\/\/www.rni-consulting.com\/?p=4585"},"modified":"2023-03-28T22:35:18","modified_gmt":"2023-03-28T20:35:18","slug":"ftc-claims-supplements","status":"publish","type":"post","link":"https:\/\/www.rni-consulting.com\/en\/ftc-claims-supplements\/","title":{"rendered":"USA – New Guidance for Advertising Claims of Supplements"},"content":{"rendered":"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/4″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][image_with_animation image_url=”4589″ image_size=”full” animation_type=”entrance” animation=”Fade In” animation_easing=”default” animation_movement_type=”transform_y” hover_animation=”none” alignment=”” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default”][\/vc_column][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”3\/4″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]\n

Back in 1998…<\/strong><\/h4>\n

In December 2022, the Federal Trade Commission (FTC), published a guidance document for advertising claims. The FTC says it is designed to replace their previous guidance published in 1998. FTC notes that some of the guidance has not changed but there are some differences that consider the history of FTC enforcement since 1998. In FTC\u2019s words:<\/p>\n

\u201cWhen it comes to ad substantiation, a lot has happened since 1998 \u2013 including more than 200 FTC law enforcement actions challenging false or deceptive health claims.\u201d<\/p><\/blockquote>\n

The latest guidance from FTC<\/strong><\/h4>\n

The 2022 guidance thus incorporates many specific examples drawing from FTC experience since 1998. This provides valuable insight into what FTC is focusing on when it comes to making advertising claims and substantiating those claims.<\/p>\n

Some highlights on the 2022 guidance from RNI:<\/p>\n